GHK-Cu Australia – Comprehensive Research Guide

GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper) is a naturally occurring copper-binding tripeptide that was first identified in human plasma. It has become one of the most widely studied peptides in Australian research laboratories, referenced across multiple experimental contexts including tissue remodelling and extracellular matrix studies. GHK-Cu consists of three amino acids (glycine, histidine, lysine) with a copper(II) ion chelated to the peptide backbone. This structure is studied in laboratory environments for its potential interactions with collagen synthesis pathways, decorin expression, and extracellular matrix organisation in controlled experimental models. Australian researchers explore GHK-Cu across several experimental contexts. The compound is referenced in preclinical studies examining tissue remodelling processes, wound environment modelling, and skin-related cellular mechanisms. It is commonly supplied in both lyophilised vial format (100mg) and topical serum formulations.